EUVIMEDEUVIMED entdecken
Crossref

Mitochondria-Targeted Microneedles Reverse Doxorubicin Resistance via Apoptosis-Ferroptosis Synergy

Tianshu Hao iD, Hanze Guo, Chenyuan Wang, Shisuo Jing, Wen Zhang, Yongnian Zeng iD, Jinxuan Hou, Zhiyin Song, Wei Li iD

ACS Nano · 01.07.2025 · 19 (25) · 23315-23333

DOI: 10.1021/acsnano.5c06302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 19.06.2025. Verfasst von Tianshu Hao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Doxorubicin, Apoptosis, Mitochondria, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinApoptosisMitochondriaDrug Resistance, NeoplasmFerroptosisAntibiotics, AntineoplasticDrug Delivery SystemsHumansAnimalsMiceFemaleNeedlesCell Line, TumorNanoparticlesMice, Inbred BALB CBreast Neoplasms

Stichwörter der Autor:innen

ROSdrug-resistant breast cancermicroneedleorganelle-specific drug deliverytargeting mitochondria

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Stomatology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
  • College of Life Sciences, Wuhan University, Wuhan 430072, Hubei, China.
  • Department of Thyroid & Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430071, China.
  • Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.

ORCID-Profile: Tianshu Hao, Yongnian Zeng, Wei Li

Förderung

  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Hubei Province
  • National Natural Science Foundation of China
  • Postdoctoral?Science?Foundation?of?Hubei?Province

Zitieren

APA

Hao, T., Guo, H., Wang, C., Jing, S., Zhang, W., Zeng, Y., Hou, J., Song, Z., & Li, W. (2025). Mitochondria-Targeted Microneedles Reverse Doxorubicin Resistance via Apoptosis-Ferroptosis Synergy. ACS Nano, 19(25), 23315-23333. https://doi.org/10.1021/acsnano.5c06302

Vancouver

Hao T, Guo H, Wang C, Jing S, Zhang W, Zeng Y, et al. Mitochondria-Targeted Microneedles Reverse Doxorubicin Resistance via Apoptosis-Ferroptosis Synergy. ACS Nano. 2025;19(25):23315-23333. doi:10.1021/acsnano.5c06302

BibTeX
@article{Hao2025,
  author = {Hao, Tianshu and Guo, Hanze and Wang, Chenyuan and Jing, Shisuo and Zhang, Wen and Zeng, Yongnian and Hou, Jinxuan and Song, Zhiyin and Li, Wei},
  title = {Mitochondria-Targeted Microneedles Reverse Doxorubicin Resistance via Apoptosis-Ferroptosis Synergy},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {25},
  pages = {23315--23333},
  doi = {10.1021/acsnano.5c06302}
}
Kostenlos starten →